TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,227,000 | -77.4% | 129,050 | -54.8% | 0.09% | -74.7% |
Q4 2021 | $5,430,000 | -66.4% | 285,809 | -41.2% | 0.34% | -70.8% |
Q3 2021 | $16,169,000 | -36.9% | 485,838 | -26.5% | 1.18% | -26.6% |
Q2 2021 | $25,639,000 | -15.0% | 660,964 | +5.6% | 1.61% | -23.5% |
Q1 2021 | $30,163,000 | -7.7% | 625,787 | -0.4% | 2.10% | -16.7% |
Q4 2020 | $32,678,000 | +432.2% | 628,172 | +173.8% | 2.52% | +280.1% |
Q3 2020 | $6,140,000 | – | 229,452 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |